Pfizer And BioNtech Begin Clinical Trial For Omicron-Specific COVID-19 Vaccine January 25, 2022 • Clark Kent 0 Pfizer and BioNTech have started a clinical trial for their Omicron-specific COVID-19 vaccine. (Visited 1 times, 1 visits today) Related posts: Witness contacts police after woman swims into Biscayne Bay and disappears FBI Releases Photos Of Pompano Beach Bank Robbery Suspect People Mourning Loss Of Archbishop Desmond Tutu Remembering Betty White Shorty’s Dadeland sells land to developers in multi-million dollar deal
